Sentinel Node Biopsies in the Management of Non-Melanoma Skin Cancer

None
Share this:
Embed*
Cite this:

Diaz-Cano, Salvador J. (2012): Sentinel Node Biopsies in the Management of Non-Melanoma Skin Cancer. figshare.

http://dx.doi.org/10.6084/m9.figshare.104480
Retrieved 04:14, Oct 25, 2014 (GMT)

Description

The routine implementation of “new” prognostic variables in tumour pathology will be worth only for cases where the prognostic information provided by other conventional methods is unreliable. Currently, the sentinel lymph node (SLN) biopsy is one those widely applied fashionable techniques aiming to identify microscopic metastatic deposits in the first lymph node draining the tumour area. The use of SLN in non-melanoma skin cancers can effectively identify a subgroup of patients at high risk of metastases, but its meaningful use must consider a careful selection of candidate patients for whom it can provide independent prognostic information, and a proper design including serial sectioning with special techniques and morphologic validation. A collaborative effort is essential for this task.

Links

Comments (0)

You must be logged in to post comments.

Cite "Filename"

Place your mouse over the citation text to select it

Embed "Sentinel Node Biopsies in the Management of Non-Melanoma Skin Cancer"

Place your mouse over the embed code to select and copy it

Claim article

You claim request was sent. I will be handled in the next 24 hours.

Close window

Feedback

We appreciate all your comments, questions, suggestions or gratitude.

Login

The username or password entered are wrong.

Reset password

Your password will be sent to your registered e-mail address.

Create account

I agree to the Terms & Conditions *